<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cavalcanti</surname>
    <given-names>R. F. P.</given-names>
   </name>
   <name>
    <surname>Gadelha</surname>
    <given-names>F. A. A. F.</given-names>
   </name>
   <name>
    <surname>de Jesus</surname>
    <given-names>T. G.</given-names>
   </name>
   <name>
    <surname>Cavalcante-Silva</surname>
    <given-names>L. H. A.</given-names>
   </name>
   <name>
    <surname>Paiva Ferreira</surname>
    <given-names>L. K. D.</given-names>
   </name>
   <name>
    <surname>Paiva Ferreira</surname>
    <given-names>L. A. M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>Warifteine and methylwarifteine inhibited the type 2 immune response on combined allergic rhinitis and asthma syndrome (CARAS) experimental model through NF-ÎºB pathway</article-title>. 
  <source>Int. Immunopharmacol.</source>
  <volume>85</volume>, 
  <fpage>106616</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.intimp.2020.106616</pub-id>
  <pub-id pub-id-type="pmid">32450529</pub-id>
 </mixed-citation>
</ref>
